MedLegal AI vs Mighty

Mighty is a free direct-to-consumer AI that settles personal-injury claims without a lawyer. MedLegal AI is the firm-side platform for plaintiff attorneys. They serve different users. Here's how they actually fit together — and where the friction is.

TL;DR

DimensionMightyMedLegal AI
Who uses itInjured consumers (no lawyer)Plaintiff law firms (attorneys + paralegals + LNCs)
PricingFree to consumers; revenue from lead-gen fees to lawyers$49–$499/mo per firm, tiered by seats and tools
Case typeAuto/MVA claims, pre-suit settlementMedical malpractice, nursing home, PI, product liability, birth injury, wrongful death, workers' comp
Complexity ceiling"The 90% of PI cases that settle pre-suit" (administrative)Everything a firm actually takes to suit or trial
Medical recordsAI pulls + analyzes, drafts to insurerFull chronology, MDS cross-check, chart-fabrication detection, expert opinion drafting, deposition prep
Attorney involvementEscalates the 10% of cases that can't be AI-settled to a lawyerAugments attorney and paralegal output; doesn't replace
HIPAAConsumer consent modelBAA with firm before any upload

The short version: they're not competing for the same customer

Mighty launched publicly in January 2026 with a simple thesis: 90% of auto-accident PI cases never go to suit. They're administrative — collect medical bills, send a demand, negotiate with the adjuster, settle. Mighty's bet is that a consumer-facing AI can do that without a lawyer at all, and the consumer keeps the 33%+ contingency fee that would otherwise go to a firm.

If Mighty wins, it takes the bottom end of the PI market — soft-tissue whiplash, minor fender-benders, urgent-care-only treatment. That's cases with no real medical-records complexity, no lien negotiation, no expert testimony.

Every case Mighty refers out is by definition in the 10% that couldn't be settled by AI alone. Those are the cases plaintiff firms actually want — higher medical specials, more complex injuries, potentially larger settlements. That's where MedLegal AI lives.

Where Mighty actually threatens law firms

Two things to watch:

  1. Lead funnel erosion. A firm that relied on "any MVA intake" to fill its pipeline will see volume drop. The cases that reach the firm will be pre-filtered to the harder, higher-value ones — which is good per case, bad per lead.
  2. Lead-gen economics. Mighty earns fees for referring the 10% to firms. That means Mighty becomes another LeadGenius/TorHoerman-style intermediary that firms have to pay. The take-rate will be negotiated and re-negotiated.

What Mighty doesn't do (that firms still need)

These are 100% of what MedLegal AI is built for. The two platforms don't overlap at the case level.

Mighty users may become MedLegal AI leads

If a firm is going to receive Mighty referrals for the 10% of cases Mighty can't settle, the firm needs faster review, not more intake. A Mighty-referred case arrives with an incomplete medical record summary, a rejected demand, and an adjuster who already said no. The firm has to work it up properly — quickly — to justify pushing past the rejection.

That's a MedLegal AI play. Drop the records into our Records Analyzer and Case Analysis tools, get a chronology and damages estimate in minutes, re-demand with better documentation. The point of Mighty's "this case is too hard for AI" is the firm's margin opportunity.

Price comparison

MightyMedLegal AI
Individual / small firmFree to consumers; firms pay lead-gen fees per referral$49/month (1 user, full toolkit)
Mid-size firmN/A (not sold to firms)$249/month (5 users, mid tier)
Multi-office firmN/A$499/month (enterprise, 20+ users)
Courtroom AI add-onN/A$99/mo (10 hrs) or $299/mo (50 hrs)

Common questions

Will Mighty kill the bottom-end PI firm?

Unclear. Firms that ran a volume-intake, low-touch soft-tissue model are most at risk. Firms that already reject small whiplash and keep higher-value cases won't feel it. Timeline: Mighty's own claims about "cases already settled by AI" are small-sample; scale will take years.

Should my firm sign up for Mighty referrals?

Read the contract carefully. Lead-gen referrals often come with exclusivity clauses, minimum-acceptance rules, and arbitration agreements. Not legal advice; your firm's ethics counsel should look at it.

Does MedLegal AI work with Mighty-referred cases?

Yes. The Records Analyzer, Case Analysis, Damages Calculator, and Demand Letter tools all take standard PDF inputs. If Mighty sends you a case file as a PDF bundle, MedLegal AI handles it exactly like any other intake.

What about insurance adjusters using AI on the other side?

Allstate, State Farm, Liberty Mutual, and Progressive all have in-house ML teams. Their claim-triage models were actually ahead of plaintiff-side AI for a decade. Tools like MedLegal AI and Mighty are the plaintiff-side catch-up. If you're not using AI on your claim, the adjuster's AI is out-preparing yours.

Try MedLegal AI

Start a free 14-day trial — all 23 tools, no credit card, BAA signed before any record upload.
Start trial → See pricing

Also compare: vs EvenUp · vs Supio · vs Filevine · vs CoCounsel · vs Clio Duo

Frequently asked questions

Is Mighty a competitor to MedLegal AI?

They serve different sides of the case. Mighty is a direct-to-consumer AI that helps injured people settle PI claims without an attorney — it's a competitor to plaintiff law firms, not to plaintiff-firm tools. MedLegal AI is the firm-side platform plaintiff attorneys use to analyze cases and prepare litigation. The threat to plaintiff firms is Mighty (taking cases away); MedLegal AI is the response (getting more value from each case you do take, so cases worth $25K+ stay profitable even when Mighty siphons the easy small cases).

Should plaintiff attorneys be worried about Mighty?

Yes for low-complexity, low-value PI cases (sub-$10K soft-tissue settlements). Mighty handles those well and clients save the contingency fee. No for medical-malpractice, severe injury, or anything requiring deposition strategy — Mighty has no specialty tools, no expert-witness network, and the insurance carriers know it. The plaintiff firm playbook in 2026 is to specialize upward (med-mal, severe PI, wrongful death) where Mighty doesn't compete, and use tools like MedLegal AI to handle those cases more efficiently.

What happens to plaintiff firms in 5 years if Mighty grows?

Solo PI firms doing volume soft-tissue cases face the most risk. Specialty plaintiff firms (med-mal, birth injury, nursing home, wrongful death) are insulated because those cases require expert testimony and Daubert challenges that consumer AI can't replicate. The smart 2026 move for general-PI firms is to specialize toward med-mal — and tools like MedLegal AI's 23-tool suite let small firms move into med-mal without the expert network a big firm requires.

Can MedLegal AI help me compete with Mighty?

Indirectly, yes. MedLegal AI doesn't generate cases — it makes the cases you have more profitable. By doing depo prep, Daubert analysis, demand-letter generation, and settlement evaluation in 1/4 the time, you can take fewer cases at higher complexity (where Mighty doesn't compete) and keep margins healthy. Many MedLegal AI users report taking 40-60% fewer cases but generating equal or higher revenue.

Is Mighty actually free for clients?

Mighty markets itself as free but takes a cut of settlements. The math vs. a 33% contingency fee is favorable for the simplest cases but tilts the other way as case complexity grows. Clients with severe injuries or med-mal claims still come out ahead with a plaintiff attorney; clients with $5K soft-tissue settlements may genuinely save money with Mighty. The volume of low-value cases that flow to Mighty is what's hollowing out the bottom of plaintiff firm caseloads.